EUVIMEDEUVIMED entdecken
StudienprotokollOpen Access · CC BY 4.0

IMPROving MYelin imaging in patients with relapsing-remitting multiple sclerosis (IMPROMYMS study): protocol for a prospective longitudinal study

Lis J M van den Boogaard, Simone Monachino, Gerhard S Drenthen iD, Stephanie A M Knippenberg iD, Svitlana Zinger, Catarina D Fernandes, Marcel Breeuwer, Oliver H H Gerlach iD, Jacobus F A Jansen

Neuroradiology · 16.11.2026

DOI: 10.1007/s00234-026-04221-3 ↗

Kurz gefasst

Studienprotokoll in der Zeitschrift Neuroradiology, online erschienen am 16.11.2026. Verfasst von Lis J M van den Boogaard und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Radiology and Nuclear Medicine, Maastricht University Medical Center+, Maastricht, Netherlands. lis.vandenboogaard@maastrichtuniversity…. Die Arbeit nennt 36 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Introduction

It is increasingly recognized that patients with relapsing-remitting multiple sclerosis (RRMS) may experience disability progression in the absence of clinical relapses and new lesions, a phenomenon known as progression independent of relapse- and magnetic resonance imaging (MRI) activity (PIRMA). The biological basis of this type of progression remains poorly understood. Demyelination is the central pathological hallmark of RRMS. Conventional clinical MRI protocols focus primarily on detecting focal lesions. However, advanced imaging techniques that quantify myelin content can provide additional insights beyond visible lesions, helping to better understand the mechanisms that drive clinical deterioration.

Objective

Therefore, this study named IMPROving MYelin imaging in patients with relapsing-remitting Multiple Sclerosis (IMPROMYMS study) aims to apply myelin imaging techniques to study clinically defined disease progression in patients with RRMS, by assessing myelin content and comparing it to patients with RRMS without progression of the disease.

Methods

In total, 97 patients with RRMS will be included and followed for 2.5 years. Participants will undergo MRI scanning at baseline and after 2 years and have regular clinical follow-up visits. Besides conventional MRI, advanced imaging sequences will be scanned, including gradient spin echo (GRASE), multi-echo gradient echo (ME-GRE), diffusion and functional MRI. Additionally, blood samples will be collected longitudinally to assess circulating biomarkers of neuroaxonal damage and astrocytic activation. Participants can also use the smartphone symptom-monitoring app MS Sherpa to enable more frequent monitoring of functional changes in daily life. In addition, 30 healthy controls will be scanned once as a reference group. In this study, we expect to find radiological prognostic markers of an increased risk of developing PIRMA, so that disease management strategies can be altered accordingly.

Schlagwörter

Stichwörter der Autor:innen

LongitudinalMRIMyelinPIRMARelapsing-remitting multiple sclerosis

Autor:innen und Institutionen

  • Department of Radiology and Nuclear Medicine, Maastricht University Medical Center+, Maastricht, Netherlands. lis.vandenboogaard@maastrichtuniversity.nl.
  • Academic MS Center Zuyd, Department of Neurology, Zuyderland Medical Center, Sittard-Geleen, Netherlands. lis.vandenboogaard@maastrichtuniversity.nl.
  • Mental Health and Neuroscience Research Institute, Maastricht University, Maastricht, Netherlands. lis.vandenboogaard@maastrichtuniversity.nl.
  • Department of Radiology and Nuclear Medicine, Maastricht University Medical Center+, Maastricht, Netherlands.
  • Department of Electrical Engineering, Eindhoven University of Technology, Eindhoven, Netherlands.
  • Department of Research, Development and Education, Epilepsy Center Kempenhaeghe, Heeze, Nederland.

ORCID-Profile: Gerhard S Drenthen, Stephanie A M Knippenberg, Oliver H H Gerlach

Zitieren

APA

van den Boogaard, L. J. M., Monachino, S., Drenthen, G. S., Knippenberg, S. A. M., Zinger, S., Fernandes, C. D., Breeuwer, M., Gerlach, O. H. H., & Jansen, J. F. A. (2026). IMPROving MYelin imaging in patients with relapsing-remitting multiple sclerosis (IMPROMYMS study): protocol for a prospective longitudinal study. Neuroradiology. https://doi.org/10.1007/s00234-026-04221-3

Vancouver

van den Boogaard LJM, Monachino S, Drenthen GS, Knippenberg SAM, Zinger S, Fernandes CD, et al. IMPROving MYelin imaging in patients with relapsing-remitting multiple sclerosis (IMPROMYMS study): protocol for a prospective longitudinal study. Neuroradiology. 2026. doi:10.1007/s00234-026-04221-3

BibTeX
@article{vandenBoogaard2026,
  author = {van den Boogaard, Lis J M and Monachino, Simone and Drenthen, Gerhard S and Knippenberg, Stephanie A M and Zinger, Svitlana and Fernandes, Catarina D and Breeuwer, Marcel and Gerlach, Oliver H H and Jansen, Jacobus F A},
  title = {IMPROving MYelin imaging in patients with relapsing-remitting multiple sclerosis (IMPROMYMS study): protocol for a prospective longitudinal study},
  journal = {Neuroradiology},
  year = {2026},
  doi = {10.1007/s00234-026-04221-3}
}
Kostenlos starten →